Transmissible Spongiform Encephalopathies Advisory Committee > August 1, 2011 Transmissible Spongiform Encephalopathies Advisory Committee Meeting Presentations

2011 Transmissible Spongiform Encephalopathies Advisory Committee Meeting Presentations

-

FDA Presentations

• August 1, 2011: Transmissible Spongiform Encephalopathies Advisory Committee Meeting Presentation: Donor Deferral / Ineligibility for Time Spent in Saudi Arabia to Reduce Risk of vCJD Transmitted by Blood and Blood Products and by Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/Ps) (PPTX - 70KB)¹
  Pedro Piccardo
• August 1, 2011: Transmissible Spongiform Encephalopathies Advisory Committee Meeting Presentation: Potential Effects of Additional Donor Deferrals on the U.S. Blood Supply (PPT - 160KB)²
  Hong Yang, Ph.D.
• August 1, 2011: Transmissible Spongiform Encephalopathies Advisory Committee Meeting Presentation: CJD and vCJD Donor Policies: Blood and Blood Components (PPT - 207KB)³
  Luisa Gregori
• August 1, 2011: Transmissible Spongiform Encephalopathies Advisory Committee Meeting Presentation: U.S. vCJD Donor Screening: Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) (PPT - 306KB)⁴
  Melissa A Greenwald, MD
• August 1, 2011: Transmissible Spongiform Encephalopathies Advisory Committee Meeting Presentation: Donor Deferral/Ineligibility for Time Spent in Saudi Arabia to Reduce Risk of vCJD Transmitted by Blood and Blood Products and by Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/Ps) (PPTX - 4.8MB)⁵
  David M. Asher

open here to download the files:
Transmissible Spongiform Encephalopathies Advisory Committee > August 1, 2011 Transmissible Spongiform Encephalopathies Advisory Committee Meeting Presentations